Cargando…
Rifabutin and Furazolidone Could Be the Candidates of the Rescue Regimen for Antibiotic-Resistant H. pylori in Korea
Background/Aim. In Korea, the rate of Helicobacter pylori (H. pylori) eradication has declined steadily as a result of increasing resistance to antibiotics, especially dual resistance to clarithromycin and metronidazole. However, microbiological culture data on drug-resistant H. pylori is lacking. T...
Autores principales: | Choi, Youn I, Jeong, Sang-Ho, Chung, Jun-Won, Park, Dong Kyun, Kim, Kyoung Oh, Kwon, Kwang An, Kim, Yoon Jae, So, Seol, Lee, Jeong Hoon, Jeong, Jin-Young, Lee, Sun-Mi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6652052/ https://www.ncbi.nlm.nih.gov/pubmed/31360270 http://dx.doi.org/10.1155/2019/9351801 |
Ejemplares similares
-
Rifabutin-based High-dose Proton-pump Inhibitor and Amoxicillin Triple Regimen as the Rescue treatment for Helicobacter pylori
por: Lim, Hyun Chul, et al.
Publicado: (2014) -
Rescue therapy with rifabutin regimen for refractory Helicobacter pylori infection with dual drug-resistant strains
por: Kuo, Chia-Jung, et al.
Publicado: (2020) -
Comparison of quadruple and triple Furazolidone containing regimens on eradication of helicobacter pylori
por: Mokhtare, Marjan, et al.
Publicado: (2015) -
Furazolidone and Helicobacter pylori Treatment
por: Talebi Bezmin Abadi, Amin
Publicado: (2015) -
Treatment with compound Lactobacillus acidophilus followed by a tetracycline- and furazolidone-containing quadruple regimen as a rescue therapy for Helicobacter pylori infection
por: Liu, Airu, et al.
Publicado: (2020)